📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Phenocell

1.1 - Company Overview

Phenocell Logo

Phenocell

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of iPSC-derived cell models and R&D outsourcing for pharmaceutical, drug discovery, ophthalmology, dermatology, and dermo-cosmetic applications, including retinal pigment epithelial cells for retinal disorder research, a Dry AMD drug discovery platform, sebocytes for acne/hyperseborrhea, melanocytes for pigmentation, and high-throughput screening and custom bioassays with high genomic stability and reproducibility.

Products and services

  • R&D Outsourcing Services: Delivers custom-engineered ophthalmology, dermatology, and cosmetics projects, including high-throughput screening and custom bioassays, supporting externalized research for drug discovery and dermo-cosmetic ingredient testing
  • Dry AMD Drug Discovery Platform: Produces disease-specific screening using iPSC-derived retinal cells to test compounds for dry Age-related Macular Degeneration within drug discovery workflows
  • IPSC-derived Retinal Pigment Epithelial Cells: Supplies genomically stable, reproducible RPE models for retinal disorders research, pharmacology, toxicology, and drug discovery applications

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Phenocell

C-Lecta Logo

C-Lecta

HQ: Germany Website
  • Description: Provider of enzyme engineering and bioprocess development for regulated markets, developing, manufacturing, and commercializing application-oriented enzyme variants. Offers the ENESYZ technology platform for customized enzymes and microbial production strains, enzymes for food and pharmaceutical industries, and biocatalytic products that replace complex chemical processes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full C-Lecta company profile →
CrestOptics Logo

CrestOptics

HQ: Italy Website
  • Description: Provider of advanced fluorescence microscopy systems and modules, including CICERO widefield and spinning disk confocal for inverted/upright setups with wide spectral range and high resolution; X-Light V3 spinning disk confocal enabling dual-camera, high-speed, large FOV imaging; DeepSIM super-resolution module; and VisiView software for integrating and optimizing imaging protocols.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CrestOptics company profile →
Ionpath Logo

Ionpath

HQ: United States Website
  • Description: Provider of ion beam–based multiplexed tissue imaging and spatial proteomics solutions, including the MIBIscope system with instrumentation, validated reagents, and visualization software; MIBI technology imaging 40+ protein markers per scan; MIBIplus single-cell analysis detecting 50+ phenotypes; Spatial Proteomic Services for segmentation, classification, and spatial analysis; and conjugated antibodies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ionpath company profile →
S-Biomedic Logo

S-Biomedic

HQ: United States Website
  • Description: Provider of skin microbiome therapeutic solutions using targeted modulation-based technology, offering Living Skin Probiotics (Cutibacterium) to aid recovery of a healthy microbiome, Sencyr Microbiome Care for acne-prone skin, CutiNaturalis Probiotic to restore microbiome balance, proprietary Modulation Technology to restore beneficial bacteria, and Living Skin Postbiotics from skin commensals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full S-Biomedic company profile →
Telo Genomics Logo

Telo Genomics

HQ: Canada Website
  • Description: Provider of telomere-based platforms for biopsies and related technologies in oncology and neurological diseases. Offerings include TeloView, which quantifies genomic instability by measuring the 3D structure and spatial organization of telomeres to assess disease aggressiveness and treatment response, and TeloView SMM, a molecular assay identifying high-risk Smouldering Multiple Myeloma patients for treatment intervention decisions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Telo Genomics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Phenocell

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Phenocell

2.2 - Growth funds investing in similar companies to Phenocell

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Phenocell

4.2 - Public trading comparable groups for Phenocell

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Phenocell

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Phenocell

What does Phenocell do?

Phenocell is a provider of iPSC-derived cell models and R&D outsourcing for pharmaceutical, drug discovery, ophthalmology, dermatology, and dermo-cosmetic applications, including retinal pigment epithelial cells for retinal disorder research, a Dry AMD drug discovery platform, sebocytes for acne/hyperseborrhea, melanocytes for pigmentation, and high-throughput screening and custom bioassays with high genomic stability and reproducibility.

Who are Phenocell's competitors?

Phenocell's competitors and similar companies include C-Lecta, CrestOptics, Ionpath, S-Biomedic, and Telo Genomics.

Where is Phenocell headquartered?

Phenocell is headquartered in France.

How many employees does Phenocell have?

Phenocell has 1,000 employees 🔒.

When was Phenocell founded?

Phenocell was founded in 2010 🔒.

What sector and industry vertical is Phenocell in?

Phenocell is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Phenocell

Who are the top strategic acquirers in Phenocell's sector and industry

Top strategic M&A buyers and acquirers in Phenocell's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Phenocell?

Top strategic M&A buyers groups and sectors for Phenocell include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Phenocell's sector and industry vertical

Which are the top PE firms investing in Phenocell's sector and industry vertical?

Top PE firms investing in Phenocell's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Phenocell's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Phenocell's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Phenocell's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Phenocell include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Phenocell's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Phenocell?

The key public trading comparables and valuation benchmarks for Phenocell include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Phenocell for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Phenocell with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Phenocell's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Phenocell with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Phenocell's' sector and industry vertical?

Access recent funding rounds and capital raises in Phenocell's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Phenocell